Completed PHASE4 INTERVENTIONAL 2-arm NCT01302275

Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain (IMIOXC)

Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain: Predictors of Response - a Randomised, Double-blind, Placebo-controlled Clinical Trial

Sponsor: Danish Pain Research Center

Conditions Peripheral Nerve Injury Polyneuropathy Postherpetic Neuralgia

Interventions Oxcarbazepine

Updated 6 times since 2017 Last updated: May 2, 2014 Started: Feb 28, 2011 Primary completion: May 31, 2013 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01302275, this PHASE4 trial focuses on Peripheral Nerve Injury and Polyneuropathy and remains completed. Sponsored by Danish Pain Research Center, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Danish Pain Research Center
Innovative Medicines Initiative
Søren H. Sindrup

Data source: Odense University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark
• Odense, Denmark